Wormentel 222 mg contains Fenbendazole, a broad-spectrum anthelmintic medication traditionally used in veterinary medicine to treat parasitic worm infections. Recently, it has gained attention for its potential off-label use in humans for eliminating intestinal worms. Fenbendazole works by disrupting the energy metabolism of parasitic worms. It binds to the tubulin protein within the parasites, inhibiting the formation of microtubules, which are essential for glucose uptake. As a result, the worms are unable to absorb nutrients, leading to energy depletion and eventual death.

In humans, when used under medical supervision, Wormentel 222 mg Tablet may help treat common parasitic infections such as roundworms, hookworms, whipworms, and certain tapeworms. Its effectiveness lies in its targeted action against the worms without significantly affecting human cells. The medication is generally taken orally, and the dosage may vary based on the severity of the infection.

However, it's important to note that Wormentel 222 mg is not officially approved for human use by regulatory agencies like the FDA. Individuals should not self-medicate without consulting a healthcare provider. While it shows promise, more clinical studies are needed to confirm its safety and efficacy in human parasitic infections. Always seek professional medical advice before using any off-label treatment.